Clinical Trial Update: Biological Therapy, Sargramostim, and Isotretinoin in Treating Patients With Relapsed or Refractory Neuroblastoma [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating biological therapy (sargramostim) and isotretinoin in relapsed or refractory neuroblastoma has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Neuroblastoma

Drugs mentioned

• ISOTRETINOIN (Isotretinoin)
• sargramostim (sargramostim)

Snippet

Sponsor: Children's Oncology Group | Conditions: Recurrent Neuroblastoma | Phase 2 | Status: COMPLETED | Results posted: 2015-02-20